Multicentric Castleman's disease developing during follow-up of sarcoidosis

被引:2
|
作者
Sawata, Tetsuro [1 ]
Bando, Masashi [1 ]
Nakayama, Masayuki [1 ]
Mato, Naoko [1 ]
Takemura, Tamiko [2 ]
Sugiyama, Yukihiko [1 ]
机构
[1] Jichi Med Univ, Dept Med, Div Pulm Med, 3311-1 Yakushiji, Shimotsuke, Tochigi 3290498, Japan
[2] Japanese Red Cross Med Ctr, Dept Pathol, Tokyo, Japan
来源
RESPIROLOGY CASE REPORTS | 2016年 / 4卷 / 04期
关键词
Interleukin-6; multicentric Castleman's disease; sarcoidosis; thoracoscopic lung biopsy;
D O I
10.1002/rcr2.168
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Pulmonary sarcoidosis is reported to have complication of lymphoproliferative disease such as malignant lymphoma, but the complication of multicentric Castleman's disease (MCD) is rarely reported. In our case of a 60-year-old woman, bilateral hilar lymphadenopathy was noted in her chest X-ray. We performed a transbronchial lung biopsy. She was diagnosed as having pulmonary sarcoidosis (Stage II). The shadow on chest X-ray disappeared without treatment. However, after 8 years, swelling of the mediastinal and abdominal lymph node, thickened bronchovascular bundle, and multiple nodular shadows were identified, and a thoracoscopic lung biopsy was performed. Based on the histopathological findings and elevated serum interleukin-6 level (75.7 pg/mL), she was diagnosed with pulmonary sarcoidosis complicated byMCD. When a change in chest X-ray findings are found during monitoring of pulmonary sarcoidosis, it is important to proceed with a thoracoscopic lung biopsy, because of the possibility of the rare complication of MCD.
引用
收藏
页数:3
相关论文
共 50 条
  • [41] Extranodal multicentric Castleman's disease with cutaneous involvement
    Skelton, HG
    Smith, KJ
    MODERN PATHOLOGY, 1998, 11 (01) : 93 - 98
  • [42] Multicentric Castleman disease with TAFRO syndrome and Sjogren's
    Li, Zi Ying
    Kim, Shirley
    Huang, SiYi
    Mian, Raza
    CLINICAL CASE REPORTS, 2019, 7 (12): : 2388 - 2392
  • [43] Alveolar Hemorrhage in Idiopathic Multicentric Castleman's Disease
    Huang, Lingtong
    Zheng, Xia
    Huang, Xiaohan
    Wang, Lijun
    Fang, Xueling
    He, Guojun
    Tang, Meng
    Shi, Huixian
    Cai, Hongliu
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 208 (05) : 613 - 615
  • [44] CLINICAL FEATURES AND PROGNOSIS OF MULTICENTRIC CASTLEMAN'S DISEASE
    Takeuchi, Naoko
    Arai, Toru
    Sasaki, Yumiko
    Matsuda, Yoshinobu
    Tokura, Sayoko
    Sonobe, Shoko
    Atagi, Shinji
    Hayashi, Seiji
    Akira, Masanori
    Kasai, Takahiko
    Kitaichi, Masanori
    Inoue, Yoshikazu
    RESPIROLOGY, 2017, 22 : 258 - 258
  • [45] HIV-associated multicentric Castleman's disease
    Naime, Fauzia de Fatima
    Fakhouri, Felipe
    Martins, Carlos Saraiva
    Couto, Wilson Jose
    RARE TUMORS, 2012, 4 (03) : 127 - 129
  • [46] Multicentric Castleman's disease treated with antivirals and immunosuppressants
    Senanayake, S
    Kelly, J
    Lloyd, A
    Waliuzzaman, Z
    Goldstein, D
    Rawlinson, W
    JOURNAL OF MEDICAL VIROLOGY, 2003, 71 (03) : 399 - 403
  • [47] Adrenalitis and anasarca in idiopathic multicentric Castleman's disease
    Chen, Luke Y. C.
    Skinnider, Brian F.
    Wilson, Don
    Fajgenbaum, David C.
    LANCET, 2021, 397 (10286): : 1749 - 1749
  • [48] Autoimmune hemolytic anemia in multicentric Castleman's disease
    Liberato, NL
    Bollati, P
    Chiofalo, F
    Filipponi, M
    Poli, M
    HAEMATOLOGICA, 1996, 81 (01) : 40 - 43
  • [49] Reversible brain involvement in multicentric Castleman's disease
    Molinero, AM
    del Río, BB
    Guerra, VS
    MEDICINA CLINICA, 2003, 121 (01): : 39 - 39
  • [50] Dose selection of siltuximab for multicentric Castleman’s disease
    Christina L. Mayer
    Lanyi Xie
    Rajesh Bandekar
    Ming Qi
    Helgi van de Velde
    Manjula Reddy
    Xiang Qin
    Hugh M. Davis
    Thomas A. Puchalski
    Cancer Chemotherapy and Pharmacology, 2015, 75 : 1037 - 1045